Hospira Inc (HSP.N)

HSP.N on New York Stock Exchange

89.93USD
28 Aug 2015
Change (% chg)

$0.01 (+0.01%)
Prev Close
$89.92
Open
$89.92
Day's High
$89.95
Day's Low
$89.91
Volume
796,631
Avg. Vol
325,850
52-wk High
$89.97
52-wk Low
$46.59

HSP.N

Chart for HSP.N

About

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $15,551.99
Shares Outstanding(Mil.): 172.93
Dividend: --
Yield (%): --

Financials

  HSP.N Industry Sector
P/E (TTM): 37.69 35.90 36.13
EPS (TTM): 2.39 -- --
ROI: 7.54 15.37 14.83
ROE: 12.09 15.94 15.69
Search Stocks

EU mergers and takeovers (Aug 5)

BRUSSELS, Aug 5 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

05 Aug 2015

Pfizer wins EU approval for $15 billion Hospira buy

BRUSSELS - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some drugs to allay competition concerns.

04 Aug 2015

CORRECTED-Pfizer wins EU approval for $15 bln Hospira buy

BRUSSELS, Aug 4 - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some drugs to allay competition concerns.

04 Aug 2015

EU mergers and takeovers (Aug 3)

BRUSSELS, Aug 3 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

03 Aug 2015

FDA warns of security flaw in Hospira infusion pumps

BOSTON - The U.S. Food and Drug Administration on Friday advised hospitals not to use Hospira Inc's Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take remote control of the system.

31 Jul 2015

FDA warns of security flaw in Hospira infusion pumps

BOSTON - The U.S. Food and Drug Administration on Friday advised hospitals not to use Hospira Inc's Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take remote control of the system.

31 Jul 2015

UPDATE 1-FDA warns of security flaw in Hospira infusion pumps

BOSTON, July 31 - The U.S. Food and Drug Administration on Friday advised hospitals not to use Hospira Inc's Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take remote control of the system.

31 Jul 2015

FDA warns of security flaw in Hospira infusion pumps

BOSTON, July 31 - The U.S. Food and Drug Administration on Friday advised hospitals to stop using Hospira Inc's Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take control of the system remotely.

31 Jul 2015

EU mergers and takeovers (July 24)

BRUSSELS, July 24 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

24 Jul 2015

Pfizer offers concessions in bid to win EU okay for Hospira deal

BRUSSELS - U.S. drugmaker Pfizer has offered concessions in a bid to win European Union regulatory approval for its $15 billion takeover of U.S. rival Hospira , the European Commission said on Tuesday.

14 Jul 2015

Earnings vs. Estimates

Search Stocks